Involvement of heparin affin regulatory peptide in human prostate cancer.
about
Structural studies reveal an important role for the pleiotrophin C-terminus in mediating interactions with chondroitin sulfateDifferential induction of glioblastoma migration and growth by two forms of pleiotrophinPleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-{gamma}/JAK/STAT1 signaling is critical for the expression of PTN in macrophages.The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.Cultured stromal cells: an in vitro model of prostatic mesenchymal biology.A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζResearch resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasiaChicken pleiotrophin: regulation of tissue specific expression by estrogen in the oviduct and distinct expression pattern in the ovarian carcinomasAntitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia.Dominant negative pleiotrophin induces tetraploidy and aneuploidy in U87MG human glioblastoma cells.The receptor protein tyrosine phosphatase (RPTP)beta/zeta is expressed in different subtypes of human breast cancer.Loss of receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ) promotes prostate cancer metastasisCCL5 secreted by senescent aged fibroblasts induces proliferation of prostate epithelial cells and expression of genes that modulate angiogenesis.Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells.Effects and characterization of paracrine factors produced by human prostate stromal cells in bioassays using rat Sertoli cells, LNCaP tumor cells, and cultured prostate epithelial cells.
P2860
Q27704056-3F835892-D338-4813-B169-0F480F000A05Q28252154-D0406A3C-C19C-4BD5-BD9D-FEBF795FFCCAQ33694574-9DE9D379-687D-42F5-B686-284B08F8166DQ33915644-DA508819-0F3F-4481-BDFC-F9C087DFEBE5Q34057789-F8137B00-B261-4B71-9B55-E1C56D400CF6Q34114284-60C55B4F-5529-4A30-8547-3954C2B1AC19Q34220101-05598AEE-CA01-475B-BE46-899DC7277DA0Q34230001-479FFE40-6CE1-4B30-8C3F-E128EE75F2F3Q34303258-9BC1E8E8-598E-4657-9242-283A57C254FFQ34609566-E3EC571C-98D8-4FB2-BEE2-568ABA5C3E45Q35748364-B1AE53C5-9729-4CC1-96D4-EE4BE59E405BQ36156124-01CB75F7-D9FE-4F3D-8F09-C03FDA8FF10DQ36418808-0D6606B1-8DD5-43EE-935D-166114A6F532Q39818502-B819499F-3035-40E6-87F2-C588690A2AA6Q43283594-D174FD34-75A8-4E62-9E2E-37C0F656B8E1Q43658903-BEF70399-FFB7-4AA9-AE8D-0DF7EBE37F9B
P2860
Involvement of heparin affin regulatory peptide in human prostate cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Involvement of heparin affin regulatory peptide in human prostate cancer.
@ast
Involvement of heparin affin regulatory peptide in human prostate cancer.
@en
type
label
Involvement of heparin affin regulatory peptide in human prostate cancer.
@ast
Involvement of heparin affin regulatory peptide in human prostate cancer.
@en
prefLabel
Involvement of heparin affin regulatory peptide in human prostate cancer.
@ast
Involvement of heparin affin regulatory peptide in human prostate cancer.
@en
P2093
P2860
P1433
P1476
Involvement of heparin affin regulatory peptide in human prostate cancer.
@en
P2093
Barritault D
Caruelle D
Caruelle JP
Gil-Diez S
Vacherot F
P2860
P304
P356
10.1002/(SICI)1097-0045(19990201)38:2<126::AID-PROS6>3.0.CO;2-C
P577
1999-02-01T00:00:00Z